Topic : The Marketing Mix - Big Picture
- Marketing 4P's - Product, Price, Place & Promotion
- Customer 4C's - Convenience, Customer solution, Communication & Costs
Customer-Product-Service Matrix
New Product-Service Matrix Existing Customer New Customer
Existing Product-Service Retention Acquisition
New Product-Service Penetration Diversification
Topic : Strategy
Aim of strategy - to create and maintain a Sustainable Competitive Advantage (SCA); meaning your company can leverage in the marketplace that cannot be easily duplicated by a competitor; ie Product Patent, Control of Raw Materials, Unique Brand Image etc.
Choose an unoccupied market rather than occupied market because all available resources can be focused on finding and growing a customer base, not engaging and fighting the competition.
4 various positions in the market place:
- Leaders - strategies is Defend and Attack itself. Blocking moves is also another defensive strategy
- Follower - strategy is Attack the leader. Must find a weakness in the leader's strength and attack at that point
- Nicher - strategy is Flank into Uncontested Areas
- Guerrilla - strategy is Redefine the Market; they put the customer first, break existing rules and disregard all policies that don't serve the customer; usually use hit-and-run attack
Unlearnt
Thought that being the market leader, the strategy is only "defending" it's market share. Not knowingly that "Attack itself" is also another strategy leaders take because if the company is going to be under attack, why not be in your own competition by innovating a new product in the market place.
Relearnt
Understanding better on this "Attack itself" could be one of Pfizer's strategy undertaken to promote Caduet (a new hypertensive drug combination of Norvasc & Lipitor) . There is a strong need to switch more current patients on Norvasc to Caduet. As Norvasc has lost it's product patent, it is therefore not in the sustainable competitive advantage, hence, our sales team need to focus more to grow Caduet as a new hypertensive treatment in order to sustain Pfizer's business and profits.